- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical use of CCR5 inhibitors in HIV and beyond ; volume:9 ; number:1 ; day:27 ; month:1 ; year:2011 ; pages:1-14 ; date:12.2011
Journal of translational medicine ; 9, Heft 1 (27.1.2011), 1-14, 12.2011
- Urheber
-
Gilliam, Bruce L.
- Beteiligte Personen und Organisationen
-
Riedel, David J.
Redfield, Robert R.
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-9-S1-S9
- URN
-
urn:nbn:de:1111-2016041439006
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gilliam, Bruce L.
- Riedel, David J.
- Redfield, Robert R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5
HIV-1 Escape From Small Molecule CCR5 Inhibitors In Vitro
Reduced CCR5 expression among Uganda HIV controllers
The HIV co-receptor CCR5 regulates osteoclast function
Bedeutung des CCR5-Chemokinrezeptors in der HIV-, HGV-Koinfektion
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction
The chemokine receptor CCR5: multi-faceted hook for HIV-1
Clearing the HIV reservoir by transplanting CCR5 deficient stem cells
RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models
CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1
Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor
Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5
HIV-1 Escape From Small Molecule CCR5 Inhibitors In Vitro
Reduced CCR5 expression among Uganda HIV controllers
The HIV co-receptor CCR5 regulates osteoclast function
Bedeutung des CCR5-Chemokinrezeptors in der HIV-, HGV-Koinfektion
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction
The chemokine receptor CCR5: multi-faceted hook for HIV-1
Clearing the HIV reservoir by transplanting CCR5 deficient stem cells
RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models
CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1
Expression of the chemokine receptor CCR5 in psoriasis and results of a randomized placebo controlled trial with a CCR5 inhibitor
Update on Aplaviroc: An HIV Entry Inhibitor Targeting CCR5
HIV-1 Escape From Small Molecule CCR5 Inhibitors In Vitro
Reduced CCR5 expression among Uganda HIV controllers
The HIV co-receptor CCR5 regulates osteoclast function
Bedeutung des CCR5-Chemokinrezeptors in der HIV-, HGV-Koinfektion
Natural anti-CCR5 antibodies in HIV-infection and -exposure
Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction
The chemokine receptor CCR5: multi-faceted hook for HIV-1
Clearing the HIV reservoir by transplanting CCR5 deficient stem cells
RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models
CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1